Skip to main content
. 2022 Sep 15;14(9):1711–1726. doi: 10.4251/wjgo.v14.i9.1711

Table 3.

Details of surgical and pathological results in the original samples before matching and after propensity score match in the two groups

Original samples
PSM
non-CC group (n = 124)
CC group (n = 126)
P value
non-CC group (n = 100)
CC group (n = 96)
P value
Interval time (d) 0.015 0.410
mean (SD) 71.7 (21.9) 77.9 (18.6) 74.5 (20.1) 76.8 (18.7)
Surgical method, n (%) 0.232 0.990
APR 42 (33.9) 31 (24.6) 30 (30.0) 29 (30.2)
LAR 77 (62.1) 91 (72.2) 66 (66.0) 63 (65.6)
Hartmann 5 (4.0) 4 (3.2) 4 (4.0) 4 (4.2)
Surgery time (h) 0.684 0.953
mean (SD) 3.0 (1.3) 3.1 (1.4) 3.0 (1.3) 3.0 (1.4)
Blood loss (mL) 0.345 0.407
mean (SD) 75.4 (51.4) 105.4 (145.5) 74.5 (47.8) 99.3 (105.0)
R0, n (%) 123 (99.2) 124 (98.4) 0.571 99 (99.0) 94 (97.9) 0.537
Numbers of dissected lymph nodes 0.194 0.502
mean (SD) 9.1 (4.9) 8.3 (5.0) 9 (4.8) 8.54 (5.0)
pT satge, n (%) 0.400 0.136
T0 21 (16.9) 31 (24.6) 17 (17.0) 28 (29.2)
T1 6 (4.8) 10 (7.0) 5 (5.0) 9 (9.4)
T2 41 (33.1) 34 (27.0) 32 (32.0) 28 (29.2)
T3 54 (43.5) 50 (39.7) 44 (44.0) 30 (31.2)
T4 2 (1.6) 1 (0.8) 2 (2.0) 1 (1.0)
pN stage, n (%) 0.541 0.712
N0 90 (72.6) 99 (78.6) 72 (72.0) 74 (77.1)
N1 26 (21.0) 21 (16.7) 22 (22.0) 17 (17.7)
N2 8 (6.5) 6 (4.8) 6 (6.0) 5 (5.2)
TRG, n (%) 0.123 0.015
0 21 (16.9) 31 (24.6) 17 (17.0) 28 (29.1)
1 43 (34.7) 51 (40.5) 33 (33.0) 41 (42.7)
2 59 (47.6) 42 (33.3) 49 (49.0) 26 (27.1) 0.176
3 1 (0.8) 2 (1.6) 1 (1.0) 1 (1.1)
pT0-2N0, n (%) 57 (46.0) 66 (52.4) 0.311 46 (46.0) 57 (59.4) 0.061
pCR, n (%) 18 (14.5) 27 (21.4) 0.155 14 (14.0) 24 (25.0) 0.051

PSM: Propensity score match; CC: Consolidation chemotherapy; APR: Abdominoperineal resection; LAR: Low anterior resection; TRG: Tumor regression grade; pCR: Pathological complete response; SD: Standard deviation.